Roivant Sciences Ltd.
ROIVNASDAQHealthcare● Active
$28.49
$-0.09(-0.31%)
Market Cap$20.5B
P/E Ratio—
52W High$32.793
52W Low$10.705
Roivant Sciences Ltd. (ROIV) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ROIV · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $4295.69M | $4886.89M | $6541.07M | $1681.82M | $2060.40M |
| Net Receivables | $789.84M | $0.00M | $82.81M | $37.64M | $6.73M |
| Inventory | $0.00M | $0.00M | $35.25M | $2.76M | $0.00M |
| Total Current Assets | $5167.38M | $5000.06M | $6731.83M | $1798.59M | $2146.52M |
| PP&E Net | $92.40M | $101.08M | $65.95M | $92.34M | $86.95M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $137.84M | $144.88M | $0.00M |
| Total Assets | $5728.05M | $5436.94M | $7222.48M | $2389.60M | $2585.13M |
| Liabilities | |||||
| Short-Term Debt | $11.15M | $9.84M | $12.00M | $40.72M | $0.00M |
| Accounts Payable | $18.00M | $23.69M | $53.23M | $37.83M | $34.58M |
| Total Current Liabilities | $281.24M | $149.41M | $266.76M | $272.45M | $184.37M |
| Long-Term Debt | $0.00M | $0.00M | $430.59M | $375.51M | $210.03M |
| Total Liabilities | $435.63M | $249.74M | $773.95M | $782.02M | $523.70M |
| Stockholders Equity | |||||
| Retained Earnings | ($501.81M) | $116.06M | $576.17M | ($3772.75M) | ($2763.72M) |
| Total Stockholders Equity | $4527.37M | $4687.60M | $5968.58M | $1157.77M | $1656.94M |
| Total Liab & Equity(computed) | $4963.00M | $4937.35M | $6742.53M | $1939.78M | $2180.64M |
| Debt Summary | |||||
| Total Debt | $107.44M | $100.17M | $499.75M | $481.40M | $283.89M |
| Net Debt | ($1315.65M) | ($2615.24M) | ($6035.96M) | ($1195.41M) | ($1776.51M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Roivant Sciences Ltd. data
About Roivant Sciences Ltd. (ROIV) Balance Sheet
Roivant Sciences Ltd. (ROIV) balance sheet shows total assets of $5.73B with cash of $4.30B. Total liabilities are $0.44B, total debt $0.11B, and stockholders equity $4.53B.
Frequently asked questions
ROIV · 4 questionsRoivant Sciences Ltd. has total debt of $0.11B with net debt of ($1.32B).
ROIV total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10